Fischer Medical Ventures Ltd.

•

fischermv.comBSE: 524743NSE: FISCHER

Market Cap₹ 2,647 Cr.

Current Price

High / Low₹ 125 / 31

Stock P/E0.0

Book Value₹ 6

Price to Book18.75

Dividend Yield0.00 %

ROCE0.5 %

ROE0.3 %

Face Value₹ 1

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Oil Gas & Consumable Fuels

Reduce

Sector economics are clouded by input volatility and uneven volume trends. WPI fuel inflation is very high at 20.05% (Jul/26), crude oil output is -5.3% YoY (2026-07), natural gas is -3.7% YoY (2026-07), and natural gas consumption is -3.0% YoY (2026-06), although refinery products grew 2.7% YoY (2026-07) and coal was 7.6% YoY (2026-07). Heavy FPI outflows of INR -15293 crore over 3 months to 2026-08-31 and negative oil-linked news flow reinforce the underweight.

Confidence

78%

View full sector analysis →

PROS

Company is almost debt free
Company has been maintaining a healthy dividend payout of 48.1%

CONS

Company is loss-making at the operating / net level
Operating cash flow has been negative in recent years
A large part of profit comes from other income (359.8% of PBT)
Receivables are growing faster than sales - a possible quality concern
Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT -23.48x)
Promoter holding has decreased over last 2 years: -12.8pp

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

Oil Gas & Consumable FuelsTradingTrading

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	ADANIENT	2894.80	52.64	391875.62	0.04	-1461.54	-249.67	32923.98	49.92	13.30	15.57
2.	PREMIERENE	999.50	27.25	45372.45	0.10	471.92	53.32	2462.59	35.25	33.72	29.03
3.	CPPLUS	3715.75	92.10	43957.48	0.04	142.20	332.51	1402.42	89.51	29.48	14.52
4.	AEGISLOG	1242.80	34.86	43622.28	0.70	544.84	210.70	2356.86	37.07	19.76	30.28
5.	REDINGTON	363.00	16.68	28378.41	1.65	453.49	94.65	34922.47	34.57	18.96	2.03
6.	HONASA	470.45	61.63	15337.81	0.64	90.45	118.87	755.95	27.00	8.99	14.58
7.	LLOYDSENT	70.95	96.45	10830.89	0.21	109.98	-55.77	563.03	70.15	12.84	18.07
8.	SGMART	825.65	83.70	10406.10	0.00	455.80	1310.71	13085.70	1044.08	10.43	4.49
9.	MMTC	62.14	20.84	9321.00	0.00	104.24	135.52	0.68	-50.00	33.46	-1423.53
10.	ENTERO	1799.70	62.46	7832.85	0.00	52.05	72.17	1940.50	38.23	10.93	5.00
11.	CELLO	346.70	24.48	7658.08	0.43	73.40	-8.99	526.72	-0.43	17.15	18.80
12.	FISCHER	37.88	88.74	2646.62	0.00	3.79	-24.30	81.92	249.34	1.13	13.73

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	0	0	0	11	0	0	0	5	5	7	1	4	1
	0	0	0	11	0	0	0	7	4	6	3	13	5
Operating Profit	-0	0	-0	-0	-0	-0	-0	-2	0	1	-1	-9	-2
OPM %	—	78.95%	—	-0.79%	—	—	—	-29.89%	8.15%	15.34%	-100.00%	-216.55%	-260.53%
Other Income	0	0	0	1	1	1	1	1	1	1	1	0	1
Interest	0	0	0	0	0	0	0	0	1	1	1	1	1
Depreciation	0	0	0	0	0	0	0	0	0	0	0	0	1
	-0	0	-0	1	1	0	1	-1	-0	1	-2	-10	-3
Tax %	-100.00%	6.25%	-0.00%	4.76%	16.83%	-10.87%	67.74%	21.24%	-177.27%	39.13%	-11.33%	11.70%	-8.48%
Net Profit	-0	0	-0	1	1	1	0	-1	-1	1	-2	-9	-4
	13	1	-1	0	0	0	0	-0	-0	0	-0	-0	-0
Equity Capital	0	2	0	54	54	54	54	64	65	65	65	65	65
Reserves	0	0	0	0	0	0	0	0	0	0	0	0	0
Promoter Pledge %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
	0	0	0	0	0	0	0	0	12	5	14
	0	0	0	0	0	0	0	0	12	7	27
Operating Profit	-0	-0	0	0	-0	-0	-0	0	1	1	—
OPM %	—	—	—	—	-13	-11	—	8	5	23	—
Other Income	0	0	0	0	0	0	0	0	1	3	4
Interest	0	0	0	0	0	0	0	0	0	0	5
Depreciation	0	0	0	0	0	0	0	0	0	0	1
	-0	-0	0	0	-0	-0	-0	-0	1	1	-14
Tax %	0	0	19	20	0	495	-18	-2,708	25	31	2
Net Profit	-0	-0	0	0	-0	0	-0	-0	0	1	-13
EPS	-0	-0	0	0	-2	9	-14	-2	0	0	—
Dividend Payout %	0	0	0	0	0	0	0	0	0	48	—
Minority Interest	0	0	0	0	0	0	0	0	0	0	0
Share of Associates	0	0	0	0	0	0	0	0	0	0	0
Adjusted EPS	-0	-0	0	0	-0	1	-1	-0	0	0	—

COMPOUNDED SALES GROWTH

10 Years:: 75%
5 Years:: 95%
3 Years:: —

COMPOUNDED PROFIT GROWTH

10 Years:: 38%
5 Years:: —
3 Years:: —

STOCK PRICE CAGR

10 Years:: —
5 Years:: —
3 Years:: —
1 Year:: -66%

RETURN ON EQUITY

10 Years:: 0%
5 Years:: 0%
3 Years:: 0%
Last Year:: 0%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
LIABILITIES	-	-	-	-	-	-	-	-	-	-
Equity Capital	3	3	0	0	0	0	0	0	54	64
	-3	-4	-0	-0	-0	-0	-0	-0	25	242
	0	0	0	0	0	0	0	1	0	0
Trade Payables	0	0	0	0	0	0	0	0	12	0
	0	0	0	0	0	0	-0	-0	1	53
Total Liabilities	0	0	0	0	0	0	0	0	92	359
ASSETS	-	-	-	-	-	-	-	-	-	-
	0	0	0	0	0	0	0	0	0	1
	0	0	0	0	0	0	0	0	41	294
	0	0	0	0	0	0	0	0	13	17
	0	0	0	0	0	0	0	0	38	46
Total Assets	0	0	0	0	0	0	0	0	92	359
Total Debt	0	0	0	0	0	0	0	1	0	0
Net Working Capital	0	0	0	0	0	0	-0	-0	38	20
Contingent Liabilities	0	0	0	0	0	0	0	0	0	0
Book Value per Share	-0.10	-0.30	-5.87	-5.61	-7.99	0.18	-13.34	-15.47	14.73	47.88
Face Value	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	-0	-0	-0	0	0	-0	-0	-0	0	-24
Cash from Investing	0	0	0	0	0	0	0	0	-38	-232
Cash from Financing	0	0	0	-0	0	-0	0	0	38	256
	-0	0	0	-0	0	-0	-0	0	-0	0
Free Cash Flow	-0	-0	-0	0	0	-0	-0	-0	0	-25
OCF / Net Profit	1.57	1.05	-8.28	0.57	-0.29	-0.41	0.76	4.00	0.20	-36.34
Cumulative 5-Year FCF	0	0	0	0	-0	-0	-0	-0	-0	-25

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
PER SHARE
EPS (₹)	-0.10	-0.19	0.07	0.26	-2.39	8.17	-13.52	-2.12	0.08	0.10
Book Value (₹)	-0.10	-0.30	-5.87	-5.61	-7.99	0.18	-13.34	-15.47	14.73	47.88
Dividend per Share (₹)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.05
Cash EPS (₹)	-0.01	-0.02	0.01	0.03	-0.24	0.82	-1.35	-0.21	0.01	0.01
PROFITABILITY
Operating Margin %	0.00%	0.00%	0.00%	0.00%	-12.52%	-10.67%	0.00%	8.47%	-1.69%	-42.86%
Net Margin %	0.00%	0.00%	0.00%	0.00%	-22.31%	85.21%	0.00%	-20.33%	3.49%	12.71%
ROE %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	1.03%	0.35%
ROCE %	-4751.97%	-358.43%	1.67%	4.75%	-25.27%	-11.19%	-95.40%	6.53%	1.39%	0.53%
	-146.97%	-226.65%	1.24%	3.55%	-32.81%	130.63%	-367.17%	-24.56%	0.87%	0.29%
EFFICIENCY
Debtor Days	0	0	0	0	0	0	0	347	204	1041
Inventory Days	0	0	0	0	0	0	0	0	0	5
Payable Days	0	0	0	0	0	0	0	0	205	499
	0	0	0	0	0	0	0	347	-1	547
FINANCIAL HEALTH
Debt to Equity (x)	-1.11x	-1.32x	-2.33x	-2.07x	-1.57x	75.10x	-1.70x	-2.15x	0.00x	0.00x
Interest Coverage (x)	-342.79x	0.00x	0.00x	0.00x	-1.28x	-0.98x	-21.69x	0.92x	35.09x	8.30x
	1.25x	6.99x	15.57x	12.95x	2.33x	4.37x	0.12x	0.40x	4.15x	3.70x
GROWTH
Revenue Growth %	-100.00%	0.00%	0.00%	0.00%	0.00%	-10.28%	-100.00%	0.00%	6322.45%	-54.72%
Operating Profit Growth %	-223.59%	-99.74%	102.10%	305.50%	-508.59%	23.57%	-972.16%	108.06%	3553.29%	119.65%
Net Profit Growth %	-224.08%	-99.16%	101.70%	303.16%	-1004.54%	442.71%	-265.43%	84.31%	1203.56%	64.65%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	103.55%	37.98%
VALUATION
P/E (x)	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	829.55x	864.00x
P/B (x)	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	42.41x	18.75x
Dividend Yield %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.01%
	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	6018.14x	4695.56x

Shareholding Pattern

Numbers in percentages

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	74.91	74.91	74.91	62.81	61.80	61.80	61.80	62.15	62.15
	5.07	5.07	5.07	5.23	5.55	5.57	4.85	4.97	5.48
	1.68	1.68	1.68	1.44	1.42	1.42	1.36	1.38	1.35
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	18.33	18.33	18.33	30.51	31.23	31.21	31.99	31.50	31.02

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-03

Outcome of Board Meeting

2026-09-03 - Fischer Medical Ventures Limited has informed the Exchange regarding Outcome of Board Meeting held on September 03, 2026.

2026-09-03

General Updates

2026-09-03 - Fischer Medical Ventures Limited has informed the Exchange about outcome of Board meeting held on 03/09/2026

2026-09-03

Record Date

2026-09-03 - Fischer Medical Ventures Limited has informed the Exchange that Record date for the purpose of Dividend is 22-Sep-2026.

2026-08-28

Press Release

2026-08-28 - Fischer Medical Ventures Limited has informed the Exchange regarding a press release dated August 28, 2026, titled "Time Medical International Ventures Launches Next-Generation CLARION 64/128-Slice AI-Driven CT System at India Health Expo 2026".

2026-08-24

Press Release

2026-08-24 - Fischer Medical Ventures Limited has informed the Exchange regarding a press release dated August 24, 2026, titled "Catanduanes Integrated Digital Healthcare Project Awarded to Time Medical Philippines Advancing the Digitalization of Universal Health Care in the Philippines".

2026-08-17

General Updates

2026-08-17 - Fischer Medical Ventures Limited has informed the Exchange on the allotment of Equity shares pursuant to conversion of warrants

2026-08-15

Resignation of Director/KMP/SMP

2026-08-15 - Fischer Medical Ventures Limited has informed the Exchange about Resignation of Director/KMP/SMP

2026-08-15

Resignation of Director/KMP/SMP

2026-08-15 - Fischer Medical Ventures Limited has informed the Exchange about Resignation of Director/KMP/SMP

2026-08-14

General Updates

2026-08-14 - Fischer Medical Ventures Limited has informed the Exchange on allotment of Equity shares pursuant to conversion of warrants

News

Recent coverage and analyst commentary for FISCHER

Loading news…

🤖

AI Stock Analyst

Fischer Medical Ventures Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

ADANIENT

2894.80

52.64

391875.62

0.04

-1461.54

-249.67

32923.98

49.92

13.30

15.57

PREMIERENE

999.50

27.25

45372.45

0.10

471.92

53.32

2462.59

35.25

33.72

29.03

CPPLUS

3715.75

92.10

43957.48

0.04

142.20

332.51

1402.42

89.51

29.48

14.52

AEGISLOG

1242.80

34.86

43622.28

0.70

544.84

210.70

2356.86

37.07

19.76

30.28

REDINGTON

363.00

16.68

28378.41

1.65

453.49

94.65

34922.47

34.57

18.96

2.03

HONASA

470.45

61.63

15337.81

0.64

90.45

118.87

755.95

27.00

8.99

14.58

LLOYDSENT

70.95

96.45

10830.89

0.21

109.98

-55.77

563.03

70.15

12.84

18.07

SGMART

825.65

83.70

10406.10

0.00

455.80

1310.71

13085.70

1044.08

10.43

4.49

MMTC

62.14

20.84

9321.00

0.00

104.24

135.52

0.68

-50.00

33.46

-1423.53

ENTERO

1799.70

62.46

7832.85

0.00

52.05

72.17

1940.50

38.23

10.93

5.00

CELLO

346.70

24.48

7658.08

0.43

73.40

-8.99

526.72

-0.43

17.15

18.80

FISCHER

37.88

88.74

2646.62

0.00

3.79

-24.30

81.92

249.34

1.13

13.73

Jun 2023

Sep 2023

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

Operating Profit

-0

-2

-1

-9

-2

OPM %

—

78.95%

—

-0.79%

—

-29.89%

8.15%

15.34%

-100.00%

-216.55%

-260.53%

Other Income

Interest

Depreciation

-0

-1

-0

-2

-10

-3

Tax %

-100.00%

6.25%

-0.00%

4.76%

16.83%

-10.87%

67.74%

21.24%

-177.27%

39.13%

-11.33%

11.70%

-8.48%

Net Profit

-0

-1

-2

-9

-4

-1

-0

Equity Capital

Reserves

Promoter Pledge %

0.00%

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

TTM

Operating Profit

-0

—

OPM %

—

-13

-11

—

Other Income

Interest

Depreciation

-0

-14

Tax %

495

-18

-2,708

Net Profit

-0

-13

EPS

-0

-2

-14

-2

—

Dividend Payout %

—

Minority Interest

Share of Associates

Adjusted EPS

-0

-1

-0

—

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

LIABILITIES

Equity Capital

-3

-4

-0

242

Trade Payables

-0

Total Liabilities

359

ASSETS

294

Total Assets

359

Total Debt

Net Working Capital

-0

Contingent Liabilities

Book Value per Share

-0.10

-0.30

-5.87

-5.61

-7.99

0.18

-13.34

-15.47

14.73

47.88

Face Value

10.00

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

-0

-24

Cash from Investing

-38

-232

Cash from Financing

-0

256

-0

Free Cash Flow

-0

-25

OCF / Net Profit

1.57

1.05

-8.28

0.57

-0.29

-0.41

0.76

4.00

0.20

-36.34

Cumulative 5-Year FCF

-0

-25

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

PER SHARE

EPS (₹)

-0.10

-0.19

0.07

0.26

-2.39

8.17

-13.52

-2.12

0.08

0.10

Book Value (₹)

-0.10

-0.30

-5.87

-5.61

-7.99

0.18

-13.34

-15.47

14.73

47.88

Dividend per Share (₹)

0.00

0.05

Cash EPS (₹)

-0.01

-0.02

0.01

0.03

-0.24

0.82

-1.35

-0.21

0.01

PROFITABILITY

Operating Margin %

0.00%

-12.52%

-10.67%

0.00%

8.47%

-1.69%

-42.86%

Net Margin %

0.00%

-22.31%

85.21%

0.00%

-20.33%

3.49%

12.71%

ROE %

0.00%

1.03%

0.35%

ROCE %

-4751.97%

-358.43%

1.67%

4.75%

-25.27%

-11.19%

-95.40%

6.53%

1.39%

0.53%

-146.97%

-226.65%

1.24%

3.55%

-32.81%

130.63%

-367.17%

-24.56%

0.87%

0.29%

EFFICIENCY

Debtor Days

347

204

1041

Inventory Days

Payable Days

205

499

347

-1

547

FINANCIAL HEALTH

Debt to Equity (x)

-1.11x

-1.32x

-2.33x

-2.07x

-1.57x

75.10x

-1.70x

-2.15x

0.00x

Interest Coverage (x)

-342.79x

0.00x

-1.28x

-0.98x

-21.69x

0.92x

35.09x

8.30x

1.25x

6.99x

15.57x

12.95x

2.33x

4.37x

0.12x

0.40x

4.15x

3.70x

GROWTH

Revenue Growth %

-100.00%

0.00%

-10.28%

-100.00%

0.00%

6322.45%

-54.72%

Operating Profit Growth %

-223.59%

-99.74%

102.10%

305.50%

-508.59%

23.57%

-972.16%

108.06%

3553.29%

119.65%

Net Profit Growth %

-224.08%

-99.16%

101.70%

303.16%

-1004.54%

442.71%

-265.43%

84.31%

1203.56%

64.65%

0.00%

103.55%

37.98%

VALUATION

P/E (x)

0.00x

829.55x

864.00x

P/B (x)

0.00x

42.41x

18.75x

Dividend Yield %

0.00%

0.01%

0.00x

6018.14x

4695.56x

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

74.91

62.81

61.80

62.15

5.07

5.23

5.55

5.57

4.85

4.97

5.48

1.68

1.44

1.42

1.36

1.38

1.35

Government

0.00

18.33

30.51

31.23

31.21

31.99

31.50

31.02

Fischer Medical Ventures Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

Fischer Medical Ventures Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI